Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Perrigo Company PLC (NYSE:PRGO)

77.27
Delayed Data
As of Aug 18
 -0.42 / -0.54%
Today’s Change
63.68
Today|||52-Week Range
99.14
-7.16%
Year-to-Date
PRGO Regular Dividend: PRGO will begin trading ex-dividend on 08/23/17 with a $0.16 dividend payable to shareholders of record as of 08/25/17.

Today’s Trading

Previous close77.69
Today’s open77.59
Day’s range77.24 - 78.76
Volume1,446,753
Average volume (3 months)1,751,883
Market cap$11.0B
Dividend yield0.83%
Data as of 4:01pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-36,609.52%
Earnings growth (this year)-9.98%
Earnings growth (next 5 years)+5.95%
Revenue growth (last year)-4.71%
P/E ratio16.3
Price/Sales2.26
Price/Book1.86

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-1.61-1.10%
BMRNBiomarin Pharmaceuti...-0.06-0.07%
ALKSAlkermes Plc-0.02-0.04%
ALNYAlnylam Pharmaceutic...+1.14+1.42%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$1.10
Annual revenue (last year)$5.3B
Annual profit (last year)-$4.0B
Net profit margin-76.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
John T. Hendrickson
Chief Financial Officer
Ron L. Winowiecki
Corporate headquarters
Dublin, Dublin

Forecasts